Farah Khan
Psychiatry · Edison, NJNPI 1639325442
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 25.2% of the total. Reporting peaked in 2019 at $854 and has fallen 78.0% since, to $188 in 2025.
Across 119 payments — averaging $12.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$380
- Takeda Pharmaceuticals U.S.A., Inc.$206
- Otsuka America Pharmaceutical, Inc.$195
- Tris Pharma Inc$190
- AbbVie$135
- Vanda Pharmaceuticals Inc.$78
- plus $327 from 11 others
What the payments were for
- Food & beverage$1,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 31 | $380 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $206 |
| Otsuka America Pharmaceutical, Inc. | 20 | $195 |
| Tris Pharma Inc | 16 | $190 |
| AbbVie | 10 | $135 |
| Vanda Pharmaceuticals Inc. | 5 | $78 |
| Alkermes, Inc. | 4 | $69 |
| Corium, LLC | 3 | $35 |
| Johnson & Johnson | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Indivior Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| Validus Pharmaceuticals LLC | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,510 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 21 | $4,603 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $592 |
| Paroxetine Hcl | 25 | $244 |
| Benztropine Mesylate | 16 | $239 |
| Alprazolam | 42 | $233 |
| Clonazepam | 26 | $194 |
| Buspirone Hcl | 11 | $155 |
| Trazodone Hcl | 14 | $131 |
| Sertraline Hcl | 33 | $112 |
| Risperidone | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Edison
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
- Anthony RostainCamden$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.